Skip to main content
Premium Trial:

Request an Annual Quote

Luminex, Exiqon

Luminex and Exiqon have recently introduced FlexmiR, a line of microRNA analysis products that incorporates Luminex's flexible xMAP technology and Exiqon's locked nucleic acids.
The companies began working together on developing miRNA-based research products in September (see RNAi News, 9/21/2006).

The product line currently includes FlexmiR Human and FlexmiR Mouse/Rat panels, which allow for the measurement of miRNA sequence expression from the public miRBase database using total RNA samples without the need for RNA size fractionation or amplification, the companies said.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.